Back to Authors

Callanan, Mary B.

0000-0002-9088-0720

A5103105005 | I145311141

Mayo Clinic

Alnylam Pharmaceuticals (United States)

Citations 1

Comparison of Patients with Primary Hyperoxaluria 1 and Late-Stage CKD from the BONAPH1DE Registry and ILLUMINATE-C Lumasiran Trial

Journal of the American Society of Nephrology | December 1, 2025 | Volume: 36 | Issue: 10S | Pages: No page available

10.1681/asn.2025b26anqr1